Cimeio Therapeutics is an applied gene editing, cellular, and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs for patients with serious and life-threatening diseases. Cimeio’s proprietary technology platform is based on the discovery of variants, which when inserted into cells allow them to maintain full function while resisting paired immunotherapy depletion. This technology has significant therapeutic potential, which Cimeio is using to develop curative treatments for patients with genetic diseases, hematologic malignancies, and severe autoimmune disorders.
Key information
- Chemicals / Pharmaceuticals
- 20 employees
- Aeschenvorstadt 36, Basel
- Cimeio Therapeutics
New jobs directly in your mailbox?
Currently, there are no job offers. Follow this company, and we’ll inform you by email as soon as new jobs become available.
No reviews yet
Help others by sharing your experience with this company as an employee or a candidate.